34184-77-5CCC(=O)[C@@]1(C)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3CC[C@@]21CQFFCYTLOTYIJMR-XMGTWHOFSA-NPromegestone is a progestin consisting of 17beta-propionylestra-4,9-dien-3-one substituted at position 17 by a methyl group. It has a role as an antineoplastic agent, a progestin and a progesterone receptor agonist. It is a 20-oxo steroid and a 3-oxo-Delta(4) steroid. It derives from a hydride of an estrane.
34184-77-5Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.
Danger
H340 (97.4%): May cause genetic defects [Danger Germ cell mutagenicity]
P203, P280, P318, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 39 reports by companies from 2 notifications to the ECHA C&L Inventory.
G - Genito urinary system and sex hormones
QG - Genito urinary system and sex hormones
DescriptionPromegestone is a potent progesterone-like agent devoid of androgenic properties, and thus masculinizing side effects. It is useful in the treatment of various gynecological conditions due to luteal insufficiency, such as premenopausal disorders, dysmenorrhea, and premenstrual syndrome.
UsesAs radioligand for the progestin receptor.
DefinitionChEBI: A progestin consisting of 17beta-propionylestra-4,9-dien-3-one substituted at position 17 by a methyl group.
Loading…
DTXSID4036510CHEMBL196003CHEBI:73390